Tokyo Tape
Sign in

Chordia Therapeutics

190A.TPharmaceutical
Filed as Chordia Therapeutics Inc. (2024-07–2026-04)
Key numbers · FY ended 2025-08
Operating income−¥1.8bn—Total assets¥2.7bn-42.1% YoYEPS (basic)¥-26.03+16.3% YoY

Full financial history and reports →

Stock price190A · View chart ↗

Open the price chart on TradingView.

Latest filings
Wed, Sep 16 · JST2 filings
16:445% STAKEChordia Therapeutics · SBI SECURITIES Co., Ltd. + 1 joint holder · 16.40% → 13.87%−2.53pp12:055% STAKEChordia Therapeutics · Nomura Securities Co., Ltd. + 2 joint holders · 22.82%new 22.82%
Fri, May 22 · JST1 filing
16:215% STAKEChordia Therapeutics · SBI SECURITIES Co., Ltd. + 1 joint holder · 17.49% → 16.40%−1.09pp
Thu, May 14 · JST1 filing
16:045% STAKEChordia Therapeutics · Kyoto University Innovation Capital Co., Ltd. · 5.79% → 4.68%−1.11pp
Thu, Apr 23 · JST1 filing
16:495% STAKEChordia Therapeutics · SBI SECURITIES Co., Ltd. + 1 joint holder · 18.65% → 17.49%−1.16pp

All filings →

Major holders (5%+) · 6
HolderStakeChangeFiled
Nomura Securities Co., Ltd.20.05%+19.37pp2026-09-16
Takeda Pharmaceutical Company Limited16.42%—2024-06-20
SBI SECURITIES Co., Ltd.13.87%-2.53pp2026-09-16
Shinsei Capital Partners, Ltd.11.06%—2024-06-21
SBI Investment Co., Ltd.6.63%-2.10pp2024-07-30

Each holder's own ratio from its most recent large-shareholding report. All 6 holders and full history →